STEVEN P JAMES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN P JAMES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN P JAMES. STEVEN P JAMES is Director in Ocera Therapeutics, Inc. ($TZYM) and Director in Oncothyreon Inc. ($ONTY) and Director in Allakos Inc. ($ALLK).
Latest Insider Trading Transactions of STEVEN P JAMES
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLK, CASC, TZYM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | ALLK | Allakos Inc. | James Steven P | Director | Option Exercise | M | 0.53 | 3,500 | 1,838 | 59,380 | |
Mar 17 2021 | ALLK | Allakos Inc. | James Steven P | Director | Buy | M | 0.53 | 3,500 | 1,838 | 3,500 | 0 to 3.5 K |
Mar 17 2021 | ALLK | Allakos Inc. | James Steven P | Director | Sell | S | 121.65 | 3,500 | 425,775 | 0 | 3.5 K to 0 (-100.00 %) |
May 28 2020 | ALLK | Allakos Inc. | James Steven P | Director | Option Exercise | A | 72.54 | 7,700 | 558,558 | 7,700 | |
Jun 11 2019 | ALLK | Allakos Inc. | James Steven P | Director | Option Exercise | A | 40.00 | 16,000 | 640,000 | 16,000 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | James Steven P | Director | Sell | U | 0.00 | 13,677 | 0 | 0 | 13.7 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 5.51 | 20,000 | 110,200 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Sep 26 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Payment of Exercise | F | 3.94 | 594 | 2,340 | 13,677 | 14.3 K to 13.7 K (-4.16 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Buy | M | 0.00 | 2,375 | 0 | 14,271 | 11.9 K to 14.3 K (+19.96 %) |
Jun 27 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | M | 0.00 | 9,058 | 0 | 0 | |
Jun 27 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Payment of Exercise | F | 3.78 | 2,265 | 8,562 | 11,896 | 14.2 K to 11.9 K (-15.99 %) |
Jun 27 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Buy | M | 0.00 | 9,058 | 0 | 14,161 | 5.1 K to 14.2 K (+177.50 %) |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 13 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | M | 0.00 | 2,148 | 0 | 0 | |
Jun 13 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | A | 0.00 | 13,927 | 0 | 13,927 | |
Jun 13 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Payment of Exercise | F | 3.34 | 537 | 1,794 | 5,103 | 5.6 K to 5.1 K (-9.52 %) |
Jun 13 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Buy | M | 0.00 | 2,148 | 0 | 5,640 | 3.5 K to 5.6 K (+61.51 %) |
Mar 14 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | M | 0.00 | 4,656 | 0 | 0 | |
Mar 14 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Payment of Exercise | F | 4.35 | 1,164 | 5,063 | 3,492 | 4.7 K to 3.5 K (-25.00 %) |
Mar 14 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Buy | M | 0.00 | 4,656 | 0 | 4,656 | 0 to 4.7 K |
Jun 28 2016 | ONTY | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | A | 0.00 | 54,347 | 0 | 54,347 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Sep 28 2015 | ONTY | Oncothyreon Inc. | James Steven P | Director | Option Exercise | A | 0.00 | 14,245 | 0 | 14,245 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 16 2015 | ONTY | Oncothyreon Inc. | James Steven P | Director | Option Exercise | A | 0.00 | 12,886 | 0 | 12,886 | |
Mar 13 2015 | ONTY | Oncothyreon Inc. | James Steven P | Director | Option Exercise | A | 0.00 | 27,932 | 0 | 27,932 |
Page: 1